Translational Stroke Research

From Target Selection to Clinical Trials

Av Paul A. Lapchak, John H. Zhang

2809 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Beskrivning

This volume sets a basis for effective translational research. Authored by experts in the field of translational stroke research, each chapter specifically addresses one or more components of preclinical stroke research. The emphasis is placed on target identification and drug development using state-of-the-art in vitro and in vivo assays, in combination with in vitro toxicology assays, AMDE and clinical design.

Produktinformation

Utgivningsdatum: 2016-08-23
Mått: 155 x 235 x 46 mm
Vikt: 1 512 g
Format: Häftad
Språk: Engelska
Serie: Springer Series in Translational Stroke Research
Antal sidor: 923
Förlag: Springer-Verlag New York Inc.
ISBN: 9781493941384

Utforska kategorier

Biovetenskap

Recensioner i media

From the reviews:“This book is an excellent review of cerebral hemorrhage, ischemia, and hypoxia as it involves pathology, pathophysiology, and cellular tolerance. It will appeal to a wide variety of investigators in stroke, neurology, and neurosurgery research. I highly recommend it in Neurology Research.” (Joseph J. Grenier, Amazon.com, February, 2014)“In Translational Stroke Research, Lapchak and Zhang have gathered an impressive, and very large, assortment of clinicians and researchers from around the world to offer reports of their studies, new ideas … and directions for future research based mainly on pleotropic and combined therapies. … The authors are to be congratulated on a great effort in furthering the available information and pitfalls in this field and pointing researchers and practitioners in a clinically significant direction. … It makes for fascinating reading!” (Elizabeth A. M. Frost, Journal of Neurosurgical Anesthesiology, Vol. 24 (4), October, 2012)

Butikslager

Ej i lager i butik.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.